Baxter International Inc (1BAX)

Milan
Currency in EUR
27.11
0.00(0.00%)
Real-time Data·
1BAX Scorecard
Full Analysis
Net income is expected to grow this year
1BAX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
27.1127.11
52 wk Range
23.7036.06
Key Statistics
Edit
Prev. Close
27.11
Open
27.11
Day's Range
27.11-27.11
52 wk Range
23.7-36.06
Volume
-
Average Volume (3m)
229
1-Year Change
-17.01%
Book Value / Share
12.76
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
1BAX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
5 analysts have revised their earnings upwards for the upcoming period
Show more

Baxter International Inc Company Profile

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; administrative sets; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors’ offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It has an agreement with Celerity Pharmaceuticals, LLC to develop acute care generic injectable premix and oncolytic products. The company operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Employees
38000
Market
Italy

Compare 1BAX to Peers and Sector

Metrics to compare
1BAX
Peers
Sector
Relationship
P/E Ratio
−57.2x−29.2x−0.5x
PEG Ratio
0.480.230.00
Price/Book
2.2x2.7x2.6x
Price / LTM Sales
1.5x1.8x2.9x
Upside (Analyst Target)
-628.8%51.4%
Fair Value Upside
Unlock−3.5%9.5%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -0.54%
Dividend Yield
2.17%
Industry Median 0.51%
Annualised payout
0.61
Paid quarterly
5-Years Growth
+0.89%
Growth Streak

Earnings

Latest Release
Feb 21, 2025
EPS / Forecast
-0.96 / --
Revenue / Forecast
2.75B / --
EPS Revisions
Last 90 days

FAQ

What Is the Baxter International Inc (1BAX) Stock Price Today?

The Baxter International Inc stock price today is 27.11.

What Stock Exchange Does Baxter International Inc Trade On?

Baxter International Inc is listed and trades on the Milan Stock Exchange stock exchange.

What Is the Stock Symbol for Baxter International Inc?

The stock symbol for Baxter International Inc is "1BAX."

Does Baxter International Inc Pay Dividends? What’s The Current Dividend Yield?

The Baxter International Inc dividend yield is 2.24%.

What Is the Baxter International Inc Market Cap?

As of today, Baxter International Inc market cap is 13.90B.

What Is Baxter International Inc's Earnings Per Share (TTM)?

The Baxter International Inc EPS (TTM) is -0.54.

From a Technical Analysis Perspective, Is 1BAX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.